• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全面的人类尿液标准,用于临床蛋白质组分析中的可比性和标准化。

Comprehensive human urine standards for comparability and standardization in clinical proteome analysis.

机构信息

Mosaiques Diagnostics and Therapeutics AG, Hannover, Germany.

出版信息

Proteomics Clin Appl. 2010 Apr;4(4):464-78. doi: 10.1002/prca.200900189. Epub 2010 Feb 3.

DOI:10.1002/prca.200900189
PMID:21137064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3064949/
Abstract

PURPOSE

Urine proteomics is emerging as a powerful tool for biomarker discovery. The purpose of this study is the development of a well-characterized "real life" sample that can be used as reference standard in urine clinical proteomics studies.

EXPERIMENTAL DESIGN

We report on the generation of male and female urine samples that are extensively characterized by different platforms and methods (CE-MS, LC-MS, LC-MS/MS, 1-D gel analysis in combination with nano-LC MS/MS (using LTQ-FT ultra), and 2-DE-MS) for their proteome and peptidome. In several cases analysis involved a definition of the actual biochemical entities, i.e. proteins/peptides associated with molecular mass and detected PTMs and the relative abundance of these compounds.

RESULTS

The combination of different technologies allowed coverage of a wide mass range revealing the advantages and complementarities of the different technologies. Application of these samples in "inter-laboratory" and "inter-platform" data comparison is also demonstrated.

CONCLUSIONS AND CLINICAL RELEVANCE

These well-characterized urine samples are freely available upon request to enable data comparison especially in the context of biomarker discovery and validation studies. It is also expected that they will provide the basis for the comprehensive characterization of the urinary proteome.

摘要

目的

尿液蛋白质组学正成为一种强大的生物标志物发现工具。本研究的目的是开发一种经过充分特征描述的“真实生活”样本,可作为尿液临床蛋白质组学研究的参考标准。

实验设计

我们报告了男性和女性尿液样本的生成,这些样本通过不同的平台和方法(CE-MS、LC-MS、LC-MS/MS、与纳升 LC-MS/MS(使用 LTQ-FT ultra)结合的 1-D 凝胶分析,以及 2-DE-MS)进行了广泛的蛋白质组学和肽组学特征描述。在某些情况下,分析涉及到实际生化实体的定义,即与分子量相关的蛋白质/肽以及检测到的 PTM 及其相对丰度。

结果

不同技术的组合允许覆盖广泛的质量范围,揭示了不同技术的优势和互补性。还展示了这些样本在“实验室间”和“平台间”数据比较中的应用。

结论和临床相关性

这些经过充分特征描述的尿液样本可根据要求免费提供,以促进数据比较,特别是在生物标志物发现和验证研究方面。预计它们还将为全面描述尿液蛋白质组学提供基础。

相似文献

1
Comprehensive human urine standards for comparability and standardization in clinical proteome analysis.全面的人类尿液标准,用于临床蛋白质组分析中的可比性和标准化。
Proteomics Clin Appl. 2010 Apr;4(4):464-78. doi: 10.1002/prca.200900189. Epub 2010 Feb 3.
2
Standard operating procedure combined with comprehensive quality control system for multiple LC-MS platforms urinary proteomics.多液相色谱-质谱联用平台尿液蛋白质组学的标准操作规程与综合质量控制系统
Nat Commun. 2025 Jan 26;16(1):1051. doi: 10.1038/s41467-025-56337-4.
3
Reproducibility Evaluation of Urinary Peptide Detection Using CE-MS.CE-MS 法检测尿肽的可重复性评估。
Molecules. 2021 Nov 30;26(23):7260. doi: 10.3390/molecules26237260.
4
A comprehensive analysis and annotation of human normal urinary proteome.全面分析和注释人类正常尿蛋白质组。
Sci Rep. 2017 Jun 8;7(1):3024. doi: 10.1038/s41598-017-03226-6.
5
Toward a standardized urine proteome analysis methodology.迈向标准化尿液蛋白质组分析方法学。
Proteomics. 2011 Mar;11(6):1160-71. doi: 10.1002/pmic.201000566. Epub 2011 Feb 16.
6
Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.蛋白质组学分析揭示了肾透明细胞癌患者尿液中分泌存在差异的蛋白质。
Urol Oncol. 2016 Jan;34(1):5.e11-25. doi: 10.1016/j.urolonc.2015.07.016. Epub 2015 Sep 26.
7
Comparison of CE-MS/MS and LC-MS/MS sequencing demonstrates significant complementarity in natural peptide identification in human urine.CE-MS/MS与LC-MS/MS测序的比较表明,在人尿液中天然肽的鉴定方面具有显著的互补性。
Electrophoresis. 2014 Apr;35(7):1060-4. doi: 10.1002/elps.201300327. Epub 2013 Nov 20.
8
The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins.人类尿液蛋白质组包含1500多种蛋白质,其中很大一部分是膜蛋白。
Genome Biol. 2006;7(9):R80. doi: 10.1186/gb-2006-7-9-R80.
9
Urine sample preparation in 96-well filter plates to characterize inflammatory and infectious diseases of the urinary tract.96 孔滤板尿样制备法用于特征性分析尿路的炎症和传染性疾病。
Adv Exp Med Biol. 2015;845:77-87. doi: 10.1007/978-94-017-9523-4_8.
10
Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction.无标记定量肽组学在鉴定肾慢性移植肾功能障碍尿液生物标志物中的应用。
Mol Cell Proteomics. 2009 Jul;8(7):1658-73. doi: 10.1074/mcp.M900059-MCP200. Epub 2009 Apr 7.

引用本文的文献

1
A Naturally Occurring Urinary Collagen Type I Alpha 1-Derived Peptide Inhibits Collagen Type I-Induced Endothelial Cell Migration at Physiological Concentrations.一种天然存在的尿源性I型胶原α1衍生肽在生理浓度下可抑制I型胶原诱导的内皮细胞迁移。
Int J Mol Sci. 2025 Aug 2;26(15):7480. doi: 10.3390/ijms26157480.
2
Future of non-invasive graft evaluation: A systematic review of proteomics in kidney transplantation.无创性移植物评估的未来:肾移植中蛋白质组学的系统综述
World J Transplant. 2025 Mar 18;15(1):96025. doi: 10.5500/wjt.v15.i1.96025.
3
Clinical Proteomics, Quo Vadis?

本文引用的文献

1
CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics.用于生物标志物发现和疾病诊断的人类尿液蛋白质组的毛细管电泳-质谱分析。
Proteomics Clin Appl. 2008 Jul 10;2(7-8):964. doi: 10.1002/prca.200800024.
2
Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody-associated vasculitis.抗中性粒细胞胞质抗体相关性血管炎的鉴别诊断和治疗干预的尿液生物标志物的鉴定和验证。
Mol Cell Proteomics. 2009 Oct;8(10):2296-307. doi: 10.1074/mcp.M800529-MCP200. Epub 2009 Jun 28.
3
Are protease inhibitors required for gel-based proteomics of kidney and urine?
临床蛋白质组学,路在何方?
Proteomics. 2025 Apr;25(7):e202400346. doi: 10.1002/pmic.202400346. Epub 2025 Feb 9.
4
Investigation of the Urinary Peptidome to Unravel Collagen Degradation in Health and Kidney Disease.尿液肽组学研究以揭示健康与肾脏疾病中的胶原蛋白降解情况。
Proteomics. 2025 Jun;25(11-12):e202400279. doi: 10.1002/pmic.202400279. Epub 2024 Dec 30.
5
Development and Challenges of Pre-Heart Failure with Preserved Ejection Fraction.射血分数保留的心力衰竭前期的发展与挑战
Rev Cardiovasc Med. 2023 Sep 25;24(9):274. doi: 10.31083/j.rcm2409274. eCollection 2023 Sep.
6
OSTEO18, a novel urinary proteomic signature, associated with osteoporosis in heart transplant recipients.OSTEO18,一种新型的尿液蛋白质组学特征,与心脏移植受者的骨质疏松症相关。
Heliyon. 2024 Jan 20;10(2):e24867. doi: 10.1016/j.heliyon.2024.e24867. eCollection 2024 Jan 30.
7
Urine Peptidome Analysis Identifies Common and Stage-Specific Markers in Early Versus Advanced CKD.尿肽组分析可识别早期与晚期慢性肾脏病中的常见及阶段特异性标志物。
Proteomes. 2023 Aug 23;11(3):25. doi: 10.3390/proteomes11030025.
8
Urinary peptides provide information about the risk of mortality across a spectrum of diseases and scenarios.尿肽提供了有关多种疾病和各种情况下死亡率风险的信息。
J Transl Med. 2023 Sep 24;21(1):663. doi: 10.1186/s12967-023-04508-6.
9
Urinary peptidomic liquid biopsy for non-invasive differential diagnosis of chronic kidney disease.尿液肽组学液体活检用于慢性肾脏病的无创性鉴别诊断。
Nephrol Dial Transplant. 2024 Feb 28;39(3):453-462. doi: 10.1093/ndt/gfad200.
10
Comparison of clean catch and bag urine using LC-MS/MS proteomics in infants.应用 LC-MS/MS 蛋白质组学比较婴幼儿清洁中段尿与尿袋尿。
Pediatr Nephrol. 2024 Jan;39(1):203-212. doi: 10.1007/s00467-023-06098-3. Epub 2023 Jul 31.
基于凝胶的肾脏和尿液蛋白质组学是否需要蛋白酶抑制剂?
J Proteome Res. 2009 Jun;8(6):3109-17. doi: 10.1021/pr900015q.
4
Should urine pH be adjusted prior to gel-based proteome analysis?在基于凝胶的蛋白质组分析之前是否应调整尿液pH值?
J Proteome Res. 2009 Jun;8(6):3206-11. doi: 10.1021/pr900127x.
5
Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney disease.常染色体显性多囊肾病患者独特尿液生物标志物谱的鉴定。
Kidney Int. 2009 Jul;76(1):89-96. doi: 10.1038/ki.2009.93. Epub 2009 Apr 1.
6
The human urinary proteome reveals high similarity between kidney aging and chronic kidney disease.人类尿液蛋白质组揭示了肾脏衰老与慢性肾病之间的高度相似性。
Proteomics. 2009 Apr;9(8):2108-17. doi: 10.1002/pmic.200800560.
7
Evaluation of urinary biomarkers for coronary artery disease, diabetes, and diabetic kidney disease.用于评估冠状动脉疾病、糖尿病和糖尿病肾病的尿液生物标志物
Diabetes Technol Ther. 2009 Jan;11(1):1-9. doi: 10.1089/dia.2008.0040.
8
Large-scale proteomics and phosphoproteomics of urinary exosomes.尿液外泌体的大规模蛋白质组学和磷酸化蛋白质组学
J Am Soc Nephrol. 2009 Feb;20(2):363-79. doi: 10.1681/ASN.2008040406. Epub 2008 Dec 3.
9
Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease.用于慢性肾脏病生物标志物评估的定量尿蛋白质组分析
J Proteome Res. 2009 Jan;8(1):268-81. doi: 10.1021/pr800401m.
10
Urine in clinical proteomics.临床蛋白质组学中的尿液
Mol Cell Proteomics. 2008 Oct;7(10):1850-62. doi: 10.1074/mcp.R800001-MCP200. Epub 2008 Jul 30.